Certain Shares of Xbrane Biopharma AB (publ) are subject to a Lock-Up Agreement Ending on 10-MAY-2021. These Shares will be under lockup for 180 days starting from 11-NOV-2020 to 10-MAY-2021. Details: Members of the Company’s board of directors, management and the existing shareholder STADA Arzneimittel AG have, subject to customary exceptions, agreed to not sell its shares in the Company for a period of 180 days following completion of the Directed Share Issue. The existing shareholder Serendipity Group AB has, subject to customary exceptions, agreed to not sell its shares in the Company for a period of 90 days following completion of the Directed Share Issue.